AI, machine learning, and robotics are fundamentally changing healthcare, says Johnson & Johnson CEO Alex Gorsky. “One of the most exciting parts of my job right now is to see the technology that’s usually equated with California and the West Coast.”
J&J Company to Pay $1.25 Million Over Expiration Dates
The U.S. Food and Drug Administration (FDA) today announced that it has settled a civil penalty case against Johnson & Johnson company Advanced Sterilization Products (ASP). ASP has agreed to pay $1.25 million over misbranded products that it distributed. Two…
Johnson & Johnson to Pay $2.5 Billion Over Hip Replacements
In January of this year a class-action lawsuit against Johnson & Johnson began. The lawsuit revolved around the company’s 2010 recall of hip replacements and whether Johnson & Johnson subsidiary DePuy Orthopaedics knew that the devices could release small bits…
Johnson & Johnson to Pay $2.2 Billion Over Risperdal Claims
The U.S. Department of Justice and the U.S. Food and Drug Administration (FDA) today announced that Janssen Pharmaceuticals has plead guilty over the misbranding of the drug Risperdal. Janssen and its company, Johnson & Johnson, will pay a total of…
Infant Motrin Recall Due To Potential Plastic Contamination Still In Effect
Infant Motrin is being recalled this week and Johnson & Johnson has voluntarily pulled 200,000 bottles off the shelves due to the risk of contamination by plastic particles. The company first issued a notice back in September about the recall…
Hip Implants Trial Against Johnson & Johnson Begins
The first of many lawsuits filed against Johnson & Johnson over the company’s 2010 recall of hip replacements has begun in Los Angeles. According to a Reuters report, 66-year-old Loren Kransky is alleging that Johnson & Johnson subsidiary DePuy knew…
Diabetes Drug Approved by U.S. FDA Committee
A U.S. Food and Drug Administration (FDA) committee this week approved the drug canagliflozin for the treatment of adults with type 2 diabetes. The Endrocrinologic and Metabolic Drugs Advisory Committee of the FDA voted 10 to 5 to approve the…